A database of historically-observed chemical replacements

Journal of Chemical Information and Modeling

Volumn 47, Issue 4, 2007, Pages 1294-1302

  Haubertin, David Y ^a   Bruneau, Pierre ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; DATABASE SYSTEMS; DRUG PRODUCTS; FUNCTIONAL GROUPS; PROTEINS;

CHEMICAL REPLACEMENTS; HYDROGEN BOND DONORS; PROTEIN BINDING;

CHEMICAL ENGINEERING;

ARTICLE; DATA BASE; DRUG DESIGN;

DATABASE MANAGEMENT SYSTEMS; DRUG DESIGN;

EID: 34547659363     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci600395u     Document Type: Article

References (29)

1. Walters, W. P.; Stahl, M. T.; Murcko, M. A. Virtual Screening - An overview. Drug Discovery Today 1998, 3 (4), 160-178.
2. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 2001, 46 (1-3), 3-26.
3. Reichardt, C. In Solvents and Solvent Effects in Organic Chemistry, 2nd ed.; VCH Verlagsgesellschaft: Weinheim, Germany, 1988; Chapter 7, pp 27-35.
4. Lewis, R. A. A general method for exploiting QSAR models in lead optimization. J. Med. Chem. 2005, 48 (5), 1638-1648.
5. Sheridan, R. P.; Hunt, P.; Culberson, J. C. Molecular transformations as a way of finding and exploiting consistent local QSAR. J. Chem. Inf. Model. 2006, 46 (1), 180-192.
6. Bruneau, P. Search for predictive generic model of aqueous solubility using Bayesian neural nets. J. Chem. Inf. Comput. Sci. 2001, 41 (6), 1605-1616.
7. Gleeson, M. P.; Waters, N. J.; Paine, S. W.; Davis, A. M. In silico human and rat Vss quantitative structure-activity relationship models. J. Med. Chem. 2006, 49 (6), 1953-1963.
8. Zuegge, J.; Schneider, G.; Coassolo, P.; Lave, T. Prediction of hepatic metabolic clearance: comparison and assessment of prediction models. Clin. Pharmacokinet. 2001, 40 (7), 553-563.
9. Bemis, G. W.; Murcko, M. A. Properties of known drugs. 2. Side chains. J. Med. Chem. 1999, 42 (25), 5095-5099.
10. Lewell, X. Q.; Judd, D. B.; Watson, S. P.; Hann, M. M. RECAP-Retrosynthetic combinatorial analysis procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci. 1998, 38 (3), 511-522.
11. Ertl, P. Cheminformatics analysis of organic substituents: Identification of the most common substituents, calculation of substituent properties, and automatic identification of druglike bioisosteric groups. J. Chem. Inf. Comput. Sci. 2003, 43 (2), 374-380.
12. Patani, G. A.; LaVoie, E. J. Bioisosterism: A rational approach in drug design. Chem. Rev. 1996, 96 (8), 3147-3176.
13. Sheridan, R. P. The most common chemical replacements in druglike compounds. J. Chem. Inf. Comput. Sci. 2002, 42 (1), 103-108.
14. Molecular Design. Drug Data Report http://www.mdl.com/products/knowledge/ drug_data_report/ (accessed March 26, 2007).
15. Advanced Chemistry Development. Structure Design Suite. http://www.acdlabs.com/products/phys_chem-lab/structuredesign/ (accessed March 26, 2007).
16. (a) Kassam, K.; Sasaki, R.; Hachey, M. R. J. Reducing the synthetic burdens of lead structure optimization: a novel software-aided approach; Presented at the DDT Conference, Boston, MA, 2005.
17. (b) ACD labs. http.//www.acdlabs.co.uk/download/publ/2005/ddt05_sds.pdf (accessed March 26, 2007).
18. Weininger, D. SMILES, A chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31-36.
19. Daylight Toolkit. http://www.daylight.com/products/toolkit.html (accessed March 26, 2007).
20. Cosgrove, D. A.; Willett, P. SLASH: A program for analysing the functional groups in molecules. J. Mol. Graphics Modell. 1998, 16 (1), 19-32.
21. Lewell, X. Q.; Jones, A. C.; Bruce, C. L.; Harper, G.; Jones, M. M.; McLay, I. M.; Bradshaw, J. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. J. Med. Chem. 2003, 46 (15), 3257-3274.
22. Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39 (15), 2887-2893.
23. Smith, D. A.; van de Waterbeemd, H. Pharmacokinetics and metabolism in early drug discovery. Curr. Opin. Chem. Biol. 1999, 3 (4), 373-378.
24. Ertl, P.; Muhlbacher, J.; Rohde, B.; Selzer, P. Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis. SAR QSAR Environ. Res. 2003, 14 (5-6), 321-328.
25. OpenEye Scientific Software OEChem. http://www.eyesopen.com (accessed March 26, 2007).
26. Kenney, J. F.; Keeping, E. S. Confidence limits for the binomial parameter and Confidence interval charts. In Mathematics of Statistics, Part 1, 3rd ed.; Van Nostrand: Princeton, NJ, 1962; Chapter 11.4, 11.5; pp 167-169.
27. Ertl P. JME molecular editor applet allowing creation or editing of molecules. http://www.molinspiration.com/jme/ (accessed March 26, 2007).
28. Sheridan, R. P.; Miller, M. D. A method for visualizing recurrent topological substructures in sets of active molecules. J. Chem. Inf. Model. 1998, 38 (5), 915-924.
29. Barker, E. J.; Buttar, D.; Cosgrove, D. A.; Gardiner, E. J.; Kitts, P.; Willett, P.; Gillet, V. J. Scaffold hopping using clique detection applied to reduced graphs. J. Chem. Inf. Model. 2006, 46 (2), 503-511.